The Medical Futurist
JUNE 21, 2025
The situation today is as follows: One company manufactures software for the radiology department which use a certain format of AI in their daily work. An average doctor will then be able to easily work with the radiological AI software, the AI software managing the EMRs, and the fourth, and eighth (etc. ) AI used in the hospital.
CDOCS
MAY 4, 2021
Couple this with the in-office technologies of CEREC® Primescan and CBCT allowed us to gain control of the technical processes necessary to manage and produce the surgical and restorative phases of treatment at one location.</span></p> Routinely a 25-40% reduction in cost as compared to the dental lab.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
GeriPal
JUNE 20, 2024
But that combination is actually quite common, and it’s quite challenging to diagnose and manage, at least in the traditional sense. We think of it really as a kind of a management tool as well. In terms of how you can, how you can manage these issues. George 19:37 Exactly, exactly. Alison 22:13 Just adding to that.
FDA Law Blog
SEPTEMBER 30, 2024
CMS did not finalize the price verification survey, which would have required manufacturers of 10 costly drugs selected annually to provide clinical information as well as information on production, distribution, research, and marketing costs, revenue and profit, and ex-U.S. Remarkably, manufacturers may not dispute a CMS notification.
FDA Law Blog
OCTOBER 17, 2023
This implies that if device technologies and features can produce a clinically meaningful impact for the treatment or diagnosis of a condition in certain populations, such data could support the case that the device satisfies the first designation criterion. Other Updates With respect to the first part of the first criterion (i.e.,
Expert insights. Personalized for you.
70 
Let's personalize your content